Covered recipient · General Payments record
STACY S OSTROW
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$1,830.33
- Reported across 72 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $559.85 | 23 |
| Education | $194.98 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $131.75 | 7 |
| Janssen Biotech, Inc. | $124.99 | 2 |
| Lilly USA, LLC | $109.67 | 4 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $94.99 | 1 |
| GENZYME CORPORATION | $70.82 | 3 |
| Arcutis Biotherapeutics, Inc. | $64.64 | 3 |
| Smith & Nephew, Inc. | $63.10 | 1 |
| LEO Pharma Inc. | $56.98 | 2 |
| Dermavant Sciences, Inc. | $20.80 | 1 |
| E.R. Squibb & Sons, L.L.C. | $17.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.24 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105162051 | CMS |
| ABBVIE INC. | $18.34 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105162053 | CMS |
| ABBVIE INC. | $25.61 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105162055 | CMS |
| ABBVIE INC. | $18.47 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105162057 | CMS |
| ABBVIE INC. | $17.73 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105162059 | CMS |
| ABBVIE INC. | $18.73 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105162061 | CMS |
| ABBVIE INC. | $13.63 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105162063 | CMS |
| Arcutis Biotherapeutics, Inc. | $20.58 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121074207 | CMS |
| Arcutis Biotherapeutics, Inc. | $21.61 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121074209 | CMS |
| Arcutis Biotherapeutics, Inc. | $22.45 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121074211 | CMS |
| Dermavant Sciences, Inc. | $20.80 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127914950 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.09 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101440822 | CMS |
| GENZYME CORPORATION | $23.38 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139793545 | CMS |
| GENZYME CORPORATION | $16.67 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139793553 | CMS |
| GENZYME CORPORATION | $30.77 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139793645 | CMS |
| Janssen Biotech, Inc. | $99.99 | 03/19/2024 | Education | Undisputed | 01/23/2026 | 1078328758 | CMS |
| Janssen Biotech, Inc. | $25.00 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078324831 | CMS |
| LEO Pharma Inc. | $28.54 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152645215 | CMS |
| LEO Pharma Inc. | $28.44 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152645217 | CMS |
| Lilly USA, LLC | $26.34 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135349627 | CMS |
| Lilly USA, LLC | $34.83 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135430801 | CMS |
| Lilly USA, LLC | $27.13 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135423531 | CMS |
| Lilly USA, LLC | $21.37 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135410763 | CMS |
| Smith+Nephew, Inc. | $63.10 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149609759 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $94.99 | 07/26/2024 | Education | Undisputed | 01/23/2026 | 1152203521 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.